Chemokines and antagonists in non-Hodgkin's lymphoma

ISSN： 1472-8222

Source： Expert Opinion on Therapeutic Targets, Vol.12, Iss.5, 2008-05, pp. : 621-635

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Non-Hodgkin's Lymphoma in the Elderly

By Caimi Paolo F. Barr Paul M. Berger Nathan A. Lazarus Hillard M.

Drugs & Aging, Vol. 27, Iss. 3, 2010-03 ,pp. : 211-238

Adis International

Access to resources Recommend Favorite

Non-Hodgkin's lymphoma

By Rule Simon

Clinical Medicine, Vol. 1, Iss. 5, 2001-09 ,pp. : 362-364

Royal College Of Physicians

Access to resources Recommend Favorite

QOL in non-Hodgkin's and Hodgkins lymphoma

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 338, 2001-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

Antiangiogenic Therapies in Non-Hodgkin's Lymphoma

Current Cancer Drug Targets, Vol. 11, Iss. 9, 2011-11 ,pp. : 1030-1043

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacokinetic evaluation of pixantrone for the treatment of non-Hodgkin's lymphoma

By Jamal-Hanjani Mariam Pettengell Ruth

Expert Opinion on Drug Metabolism and Toxicology, Vol. 7, Iss. 11, 2011-11 ,pp. : 1441-1448

Informa Healthcare

Access to resources Recommend Favorite